RARE PHOTOS: 48 | Rare Historical Photos

CSL to bandage cost pressures to stem bleeding profits

Biomedical giant CSL has pledged to repair margins as cost pressures and volatile global currencies continue to bruise profits at the vaccine and plasma leader.

AAP · Oct 11, 2023

Michigan State instructor discovered to have meth lab conviction

Brendan Doyle, a kinesiology instructor, had been reportedly exhibiting erratic behaviour

The Independent UK · Oct 10, 2023

3 Pharma Stocks Ready to Shine This Week

The pharmaceutical industry is expected to thrive, driven by the increasing need for chronic disease management and the requirements of an aging demographic. Given the industry’s solid prospects, quality pharma stocks Organon (OGN), GoodRx Holdings (GDRX), and Collegium Pharmaceutical (COLL) could be solid buys this week. Read on….

StockNews.com · Oct 10, 2023

Top 3 Biotech Stocks Leading the Way This October

The biotech industry is well-positioned for strong growth thanks to increasing demand for high-quality treatments for chronic diseases. Given this backdrop, quality biotech stocks Jazz Pharmaceuticals (JAZZ), Amgen (AMGN), and Gilead Sciences (GILD) could be solid buys for October. Read on….

StockNews.com · Oct 3, 2023

Letters to The Editor — October 3, 2023

Readers’ mail to The Hindu’s Letters to The Editor

The Hindu · Oct 2, 2023

Johnson & Johnson not to enforce patents on TB drug

“The announcement will finally pave the way for unfettered access to affordable generic versions of bedaquiline for all people”

The Hindu · Oct 1, 2023

Have a complaint about CVS? So do pharmacists: Many just walked out

After a large walkout forced at least a dozen stores to shut down in the Kansas City area, CVS promises change. But critics say the crisis in staffing and unfair pay extends beyond that market.

WEKU · Sep 29, 2023

Vivek Ramaswamy is furiously defending his business ties in China. What are they?

‘Vivek’s first business had a subsidiary in China’ which was closed ‘as the risks of doing business in China became apparent,’ Ramaswamy spokesperson says

The Independent UK · Sep 28, 2023

3 Biotech Stocks to Buy Instead of Palatin Technologies (PTN)

While Palatin Technologies (PTN) has faced challenges with declining share price, negative analyst projections, and limited profitability, it's worth noting the consistent growth in the broader biotech industry. Thus, investors could find more stable returns in robust biotech stocks Protalix BioTherapeutics (PLX), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) instead. Read…

StockNews.com · Sep 28, 2023

3 A-Rated Pharma Buys for October

The growing adoption of innovative drugs and the heightened demand for personalized medicines are expected to boost the pharma industry. Therefore, it might be wise to buy fundamentally strong pharma stocks Neurocrine Biosciences (NBIX), Novo Nordisk (NVO), and AstraZeneca PLC (AZN), which are rated an A (Strong Buy) in our…

StockNews.com · Sep 28, 2023